X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs UNICHEM LAB - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER UNICHEM LAB PFIZER/
UNICHEM LAB
 
P/E (TTM) x 38.4 -66.4 - View Chart
P/BV x 5.6 0.7 759.8% View Chart
Dividend Yield % 0.6 2.3 26.5%  

Financials

 PFIZER   UNICHEM LAB
EQUITY SHARE DATA
    PFIZER
Mar-18
UNICHEM LAB
Mar-18
PFIZER/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs2,365382 619.1%   
Low Rs1,625234 694.1%   
Sales per share (Unadj.) Rs430.3116.3 370.0%  
Earnings per share (Unadj.) Rs78.7-18.9 -416.0%  
Cash flow per share (Unadj.) Rs93.2-11.7 -793.7%  
Dividends per share (Unadj.) Rs20.005.00 400.0%  
Dividend yield (eoy) %1.01.6 61.8%  
Book value per share (Unadj.) Rs586.5381.0 153.9%  
Shares outstanding (eoy) m45.7570.34 65.0%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.62.6 175.0%   
Avg P/E ratio x25.3-16.3 -155.7%  
P/CF ratio (eoy) x21.4-26.2 -81.6%  
Price / Book Value ratio x3.40.8 420.7%  
Dividend payout %25.4-26.4 -96.2%   
Avg Mkt Cap Rs m91,27121,668 421.2%   
No. of employees `0002.62.3 115.4%   
Total wages/salary Rs m3,1432,006 156.6%   
Avg. sales/employee Rs Th7,484.83,587.8 208.6%   
Avg. wages/employee Rs Th1,195.0880.0 135.8%   
Avg. net profit/employee Rs Th1,369.1-583.7 -234.5%   
INCOME DATA
Net Sales Rs m19,6858,180 240.6%  
Other income Rs m1,143610 187.3%   
Total revenues Rs m20,8288,790 236.9%   
Gross profit Rs m5,003-1,320 -379.0%  
Depreciation Rs m663505 131.2%   
Interest Rs m480 5.2%   
Profit before tax Rs m5,479-1,295 -423.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,87833 5,620.6%   
Profit after tax Rs m3,601-1,331 -270.5%  
Gross profit margin %25.4-16.1 -157.5%  
Effective tax rate %34.3-2.6 -1,328.7%   
Net profit margin %18.3-16.3 -112.4%  
BALANCE SHEET DATA
Current assets Rs m24,16723,318 103.6%   
Current liabilities Rs m9,5444,635 205.9%   
Net working cap to sales %74.3228.4 32.5%  
Current ratio x2.55.0 50.3%  
Inventory Days Days55122 45.2%  
Debtors Days Days29121 23.6%  
Net fixed assets Rs m9,5148,163 116.5%   
Share capital Rs m458141 325.2%   
"Free" reserves Rs m26,37526,660 98.9%   
Net worth Rs m26,83226,801 100.1%   
Long term debt Rs m253 757.6%   
Total assets Rs m36,90031,890 115.7%  
Interest coverage x1,305.5-15.2 -8,605.5%   
Debt to equity ratio x00 756.7%  
Sales to assets ratio x0.50.3 208.0%   
Return on assets %9.8-3.9 -249.1%  
Return on equity %13.4-5.0 -270.2%  
Return on capital %20.4-4.5 -449.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m224,356 0.5%   
Fx outflow Rs m1,4890-   
Net fx Rs m-1,4664,356 -33.7%   
CASH FLOW
From Operations Rs m3,318-1,123 -295.4%  
From Investments Rs m-2,38316,487 -14.5%  
From Financial Activity Rs m-1,104-8,811 12.5%  
Net Cashflow Rs m-1696,552 -2.6%  

Share Holding

Indian Promoters % 0.0 50.1 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 15.1 49.7%  
FIIs % 4.9 3.0 163.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 31.7 74.8%  
Shareholders   85,207 20,176 422.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   AJANTA PHARMA  GLENMARK PHARMA  SUN PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 290 Points; Realty and PSU Stocks Witness Selling(Closing)

After opening the day on a negative note, share markets in India continued their downtrend throughout the day and ended in red.

Related Views on News

PFIZER Announces Quarterly Results (1QFY19); Net Profit Up 60.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, PFIZER has posted a net profit of Rs 918 m (up 60.6% YoY). Sales on the other hand came in at Rs 5 bn (up 18.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

As the Rupee Takes a Record Plunge, These Pharma Stocks Gain the Most(Sector Info)

Sep 5, 2018

Most pharma stocks were trading with gains amid rupee's fresh fall. Does that mean pharma stocks are back in vogue?

Why Arun Jaitley's Demonetisation Defence Doesn't Add Up(Vivek Kaul's Diary)

Sep 5, 2018

The tax collected has gone up a little but the question is at what cost.

The Cream of Small Cap Stocks(Profit Hunter)

Sep 5, 2018

Akin to skimming the cream off milk, one needs to learn to skim the cream off small cap stocks.

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Sep 18, 2018 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS